Medicine and Dentistry
Prostate Cancer
100%
Gene Mutation
100%
Downregulation
100%
Suppressor Gene
100%
Metastasis Suppressor
100%
CD82 Antigen
100%
Protein Expression
28%
Metastatic Carcinoma
28%
Lymph Node Metastasis
14%
Epithelial Cell
7%
Prostate Hypertrophy
7%
Androgen
7%
Cancer Cell
7%
Cell Membrane
7%
Ablation Therapy
7%
Primary Tumor
7%
Exon
7%
Point Mutation
7%
Human Chromosome
7%
Single Strand Conformation Polymorphism
7%
DNA Flanking Region
7%
Keyphrases
Gene mutation
100%
Allelic Loss
100%
Prostatic Cancer
100%
KAI1
100%
Metastasis Suppressor
100%
Protein Expression
28%
Metastasis
14%
Lymph Node Metastasis
14%
Untreated Patients
14%
Plasma Membrane
7%
Cancer Cells
7%
Benign Prostatic Hyperplasia
7%
Epithelial Cells
7%
Immunohistochemical Staining
7%
Point mutation
7%
Metastatic Disease
7%
Dysregulation
7%
Exon
7%
Tumor Metastasis
7%
Primary Cancer
7%
Human Chromosomes
7%
Single-strand Conformation Polymorphism
7%
Microsatellite Analysis
7%
Loss of Expression
7%
Stromal Compartment
7%
Cancer-associated Proteins
7%
Androgen Ablation Therapy
7%
Tissue Bank
7%
Biochemistry, Genetics and Molecular Biology
Protein Expression
100%
Gene Mutation
100%
Downregulation
100%
Suppressor Gene
100%
Metastasis Suppressor
100%
Cell Membrane
25%
Cancer Cell
25%
Point Mutation
25%
Exon
25%
Human Chromosome
25%
DNA Flanking Region
25%
Microsatellite
25%
Neuroscience
Gene Mutation
100%
Suppressor Gene
100%
CD82 Antigen
100%
Metastasis Suppressor
100%
Protein Expression
28%
Lymph Node
14%
Staining Technique
7%
Cell Membrane
7%
Epithelial Cells
7%
Point Mutation
7%
Androgen
7%
Exon
7%
DNA Flanking Region
7%
Hyperplasia
7%
Human Chromosome
7%
Microsatellite
7%
Immunology and Microbiology
Downregulation
100%
Gene Mutation
100%
CD82 Antigen
100%
Suppressor Gene
100%
Protein Expression
28%
Lymph Node
14%
Cell Membrane
7%
Cancer Cell
7%
Point Mutation
7%
Exon
7%
DNA Flanking Region
7%
Human Chromosome
7%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
CD82 Antigen
100%
Metastasis
14%
Lymph Node Metastasis
14%
Malignant Neoplasm
7%
Androgen
7%
Primary Tumor
7%
Prostate Hypertrophy
7%